In conclusion, the differences in Il-6, TNF-α, HGF, and TGF-β observed in liver donors between the portal and hepatic veins seem to result from their removal by healthy liver, which is absent in liver graft recipients with hepatic insufficiency. Here, IL6 is linked to Hepatic failure.